Antiplatelet monotherapy
Showing 1 - 25 of 4,232
Clopidogrel vs. Aspirin Monotherapy After Drug-eluting Stent
Active, not recruiting
- Coronary Artery Disease
- Atheroscleroses, Coronary
- Antiplatelet Agents
- (no location specified)
Oct 1, 2022
Intracranial Aneurysm, Stent Complication Trial (Ticagrelor monotherapy, Dual Antiplatelet Therapy)
Not yet recruiting
- Intracranial Aneurysm
- Stent Complication
- Ticagrelor monotherapy
- Dual Antiplatelet Therapy
- (no location specified)
Aug 23, 2023
Intracerebral Hemorrhage Trial in Beijing, Shanghai (Start antiplatelet monotherapy)
Recruiting
- Intracerebral Hemorrhage
- Start antiplatelet monotherapy
-
Beijing, Beijing, China
- +1 more
Mar 14, 2022
Acute Coronary Syndrome Trial in São Paulo (Dual antiplatelet therapy: Acetylsalicylic acid + ticagrelor OR Acetylsalicylic acid
Recruiting
- Acute Coronary Syndrome
- Dual antiplatelet therapy: Acetylsalicylic acid + ticagrelor OR Acetylsalicylic acid + prasugrel
- Monotherapy: Ticagrelor alone OR Prasugrel alone
-
São Paulo, BrazilHospital Israelita Albert Einstein
Mar 2, 2023
Ischemic Heart Disease Trial in Seoul (Clopidogrel monotherapy, Aspirin monotherapy, zotarolimus-eluting stent (Resolute Onyx
Recruiting
- Ischemic Heart Disease
- Clopidogrel monotherapy
- +2 more
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Oct 13, 2022
Acute Coronary Syndrome, Coronary Artery Ectasia Trial in Mexico City (Rivaroxaban 15 MG, Acetylsalicylic acid 100mg,
Recruiting
- Acute Coronary Syndrome
- Coronary Artery Ectasia
- Rivaroxaban 15 MG
- +2 more
-
Mexico City, Mexico
- +1 more
Jan 31, 2022
Coronary Artery Disease Trial in Jacksonville (aspirin plus clopidogrel, prasugrel or ticagrelor)
Not yet recruiting
- Coronary Artery Disease
- aspirin plus clopidogrel
- prasugrel or ticagrelor
-
Jacksonville, FloridaUniversity of Florida
Jan 4, 2023
Coronary Artery Disease Trial in Seoul (Type of stent, Duration of DAPT)
Recruiting
- Coronary Artery Disease
- Type of stent
- Duration of DAPT
-
Seoul, Korea, Republic ofSamsung Medical Center
May 8, 2022
Coronary Heart Disease Trial in Seoul (Clopidogrel, Aspirin)
Completed
- Coronary Heart Disease
-
Seoul, Korea, Republic ofSeoul National University Hospital
Apr 10, 2021
Antiplatelet Drug, Acute Coronary Syndrome, Angioplasty, Balloon Trial in Xi'an (Aspirin 100mg for 1-month (immediately after
Recruiting
- Antiplatelet Drug
- +2 more
- Aspirin 100mg for 1-month (immediately after PCI)
- +4 more
-
Xi'an, Shannxi, ChinaLing Tao
Jul 20, 2022
ST Elevated Myocardial Infarction, Dual Antiplatelet Therapy Trial in Dordrecht, Rotterdam (Prasugrel based short DAPT,
Recruiting
- ST Elevated Myocardial Infarction
- Dual Antiplatelet Therapy
- Prasugrel based short DAPT
- +3 more
-
Dordrecht, Netherlands
- +2 more
Aug 5, 2022
Coronary Artery Disease, Myocardial Infarction Trial in Ottawa (Active Comparator: Dual Antiplatelet Therapy (DAPT) - Aspirin 81
Suspended
- Coronary Artery Disease
- Myocardial Infarction
- Active Comparator: Dual Antiplatelet Therapy (DAPT) - Aspirin 81 mg + Ticagrelor 60mg twice daily
- +2 more
-
Ottawa, Ontario, CanadaUniversity of Ottawa Heart Institute
Feb 17, 2022
Acute Coronary Syndrome Trial in Brazil (Antiplatelet Monotherapy)
Recruiting
- Acute Coronary Syndrome
- Antiplatelet Monotherapy
-
Rio Branco, Acre, Brazil
- +48 more
Aug 3, 2022
Diabetes, Type 2, Coronary Artery Disease Trial in Jacksonville (Ticagrelor monotherapy, Ticagrelor plus aspirin, Clopidogrel
Recruiting
- Diabetes Mellitus, Type 2
- Coronary Artery Disease
- Ticagrelor monotherapy
- +2 more
-
Jacksonville, FloridaUniversity of Florida
May 31, 2022
Coronary Artery Disease Trial in Worldwide (Angiography-derived physiology guidance/Local routine diagnostic procedure (LRDP)
Recruiting
- Coronary Artery Disease
- Angiography-derived physiology guidance/Local routine diagnostic procedure (LRDP) and usual care
-
Aalst, Belgium
- +13 more
Jul 27, 2022
ST Elevation Myocardial Infarction Trial in Busan (ticagrelor monotherapy, Aspirin with P2Y12 receptor inhibitor)
Unknown status
- ST Elevation Myocardial Infarction
- ticagrelor monotherapy
- Aspirin with P2Y12 receptor inhibitor
-
Busan, Korea, Republic ofDepartment of Internal Medicine,Dong-A University College of Med
Dec 18, 2020
Gastrointestinal Injury, Ischemic Heart Disease Trial in Shenyang (Aspirin + clopidogrel, Clopidogrel monotherapy, Aspirin
Recruiting
- Gastrointestinal Injury
- Ischemic Heart Disease
- Aspirin + clopidogrel
- +2 more
-
Shenyang, Liaoning, ChinaGeneral Hospital of Shenyang Military Region
Oct 15, 2020
ST Elevation Myocardial Infarction Trial in Netherlands (Ticagrelor, Aspirin)
Recruiting
- ST Elevation Myocardial Infarction
-
Alkmaar, Netherlands
- +4 more
Aug 3, 2023
Coronary Artery Disease Trial in Seoul (Clopidogrel monotherapy, Tailored anti-platelet therapy)
Not yet recruiting
- Coronary Artery Disease
- Clopidogrel monotherapy
- Tailored anti-platelet therapy
-
Seoul, Korea, Republic ofSeverance Hospital
Jul 3, 2023
Intracranial Hemorrhages, Atrial Fibrillation Trial in Worldwide (Edoxaban, Non-anticoagulant medical therapy)
Recruiting
- Intracranial Hemorrhages
- Atrial Fibrillation
- Edoxaban
- Non-anticoagulant medical therapy
-
Elk Grove Village, Illinois
- +152 more
Jan 23, 2023
Bleeding Complications Trial in Rochester (Clopidogrel, Prasugrel, Tricagrelor)
Active, not recruiting
- Bleeding Complications
- Clopidogrel
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Dec 31, 2022
Coronary Artery Disease Trial in Seoul (1 Month vs. 12 Months DAPT)
Recruiting
- Coronary Artery Disease
- 1 Month vs. 12 Months DAPT
-
Seoul, Korea, Republic ofSeoul St. Mary's Hospital
Mar 5, 2023
ST-segment Elevation Myocardial Infarction (STEMI) Trial (No aspirin (Prasugurel monotherapy), 12-month DAPT)
Not yet recruiting
- ST-segment Elevation Myocardial Infarction (STEMI)
- No aspirin (Prasugurel monotherapy)
- 12-month DAPT
- (no location specified)
Feb 1, 2023
Atrial Fibrillation, Coronary Artery Disease Trial (Rivaroxaban)
Not yet recruiting
- Atrial Fibrillation
- Coronary Artery Disease
- (no location specified)
Oct 22, 2023
Acute Coronary Syndrome, CYP2C19 Polymorphism Trial in Nieuwegein (Clopidogrel)
Recruiting
- Acute Coronary Syndrome
- CYP2C19 Polymorphism
-
Nieuwegein, Utrecht, NetherlandsSt. Antonius Hospital
Jun 27, 2023